Vankadari N, Shepherd DC, Carter SD, Ghosal D. Three-dimensional insights into human enveloped viruses in vitro and in situ. Biochem Soc Trans. 2022;50(1):95–105.
Article CAS PubMed PubMed Central Google Scholar
Cheng N, Liu M, Li W, Sun BY, Liu D, Wang G, Shi J, Li L. Protein post-translational modification in SARS-CoV-2 and host interaction. Front Immunol. 2022;13:1068449.
Article CAS PubMed Google Scholar
Chaudhuri S, Symons JA, Deval J. Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond. Antiviral Res. 2018;155:76–88.
Article CAS PubMed PubMed Central Google Scholar
Namasivayam V, Palaniappan S, Vanangamudi M. Repurposing drugs targeting epidemic viruses. Drug Discov Today. 2022;27(7):1874–94.
Article CAS PubMed Google Scholar
Boldescu V, Behnam MAM, Vasilakis N, Klein CD. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond. Nat Rev Drug Discov. 2017;16(8):565–86.
Article CAS PubMed PubMed Central Google Scholar
Perera N, Brun J, Alonzi DS, Tyrrell BE, Miller JL, Zitzmann N. Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells. Antiviral Res. 2022;199: 105269.
Article CAS PubMed PubMed Central Google Scholar
Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov. 2018;17(1):35–56.
Article CAS PubMed Google Scholar
Zheng Y, Li S, Song K, Ye J, Li W, Zhong Y, Feng Z, Liang S, Cai Z, Xu K. A broad antiviral strategy: inhibitors of human DHODH pave the way for host-targeting antivirals against emerging and re-emerging viruses. Viruses. 2022;14(5):928.
Article CAS PubMed PubMed Central Google Scholar
Kumar N, Sharma S, Kumar R, Tripathi BN, Barua S, Ly H, Rouse BT. Host-directed antiviral therapy. Clin Microbiol Rev. 2020;33(3):168–90.
Watanabe Y, Bowden TA, Wilson IA, Crispin M. Exploitation of glycosylation in enveloped virus pathobiology. Biochim Biophys Acta Gen Subj. 2019;1863(10):1480–97.
Article CAS PubMed PubMed Central Google Scholar
Dhara D, Dhara A, Bennett J, Murphy PV. Cyclisations and strategies for stereoselective synthesis of piperidine iminosugars. Chem Rec. 2021;21(11):2958–79.
Article CAS PubMed Google Scholar
Conforti I, Marra A. Iminosugars as glycosyltransferase inhibitors. Org Biomol Chem. 2021;19(25):5439–75.
Article CAS PubMed Google Scholar
Miller JL, Tyrrell BE, Zitzmann N. Mechanisms of antiviral activity of iminosugars against dengue virus. Adv Exp Med Biol. 2018;1062:277–301.
Article CAS PubMed PubMed Central Google Scholar
Evans DeWald L, Starr C, Butters T, Treston A, Warfield KL. Iminosugars: a host-targeted approach to combat Flaviviridae infections. Antiviral Res. 2020;184: 104881.
Article CAS PubMed PubMed Central Google Scholar
Ferjancic Z, Bihelovic F, Vulovic B, Matovic R, Trmcic M, Jankovic A, Pavlovic M, Djurkovic F, Prodanovic R, Djurdjevic Djelmas A, et al. Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies. J Enzyme Inhib Med Chem. 2024;39(1):2289007.
Miglani V, Sharma P, Kumar Narula A. Investigation of iminosugars as antiviral agents against SARS-CoV-2 main protease: inhibitor design and optimization, molecular docking, and molecular dynamics studies to explore potential inhibitory effect of 1-deoxynojirmycin series. Curr Comput Aided Drug Des. 2023.
Tyrrell BE, Sayce AC, Warfield KL, Miller JL, Zitzmann N. Iminosugars: promising therapeutics for influenza infection. Crit Rev Microbiol. 2017;43(5):521–45.
Article CAS PubMed Google Scholar
Li Y, Liu D, Wang Y, Su W, Liu G, Dong W. The importance of glycans of viral and host proteins in enveloped virus infection. Front Immunol. 2021;12: 638573.
Article CAS PubMed PubMed Central Google Scholar
Schön K, Lepenies B, Goyette-Desjardins G. Impact of protein glycosylation on the design of viral vaccines. Adv Biochem Eng Biotechnol. 2021;175:319–54.
Wang Q, Groenendyk J, Michalak M. Glycoprotein quality control and endoplasmic reticulum stress. Molecules. 2015;20(8):13689–704.
Article CAS PubMed PubMed Central Google Scholar
Rey FA, Lok SM. Common features of enveloped viruses and implications for immunogen design for next-generation vaccines. Cell. 2018;172(6):1319–34.
Article CAS PubMed PubMed Central Google Scholar
Mehta A, Ouzounov S, Jordan R, Simsek E, Lu X, Moriarty RM, Jacob G, Dwek RA, Block TM. Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ. Antiviral Chem Chemother. 2002;13(5):299–304.
Liu H, Chen C, Liao S, Sohaii DK, Cruz CRY, Burdo TH, Cradick TJ, Mehta A, Barrero C, Florez M, et al. Strategic self-limiting production of infectious HIV particles by CRISPR in permissive cells. Mol Ther Nucleic Acids. 2023;32:1010–25.
Article CAS PubMed PubMed Central Google Scholar
Sadat MA, Moir S, Chun TW, Lusso P, Kaplan G, Wolfe L, Memoli MJ, He M, Vega H, Kim LJY, et al. Glycosylation, hypogammaglobulinemia, and resistance to viral infections. N Engl J Med. 2014;370(17):1615–25.
Article CAS PubMed PubMed Central Google Scholar
Dobrica MO, Lazar C, Branza-Nichita N. N-glycosylation and N-glycan processing in HBV biology and pathogenesis. Cells. 2020;9(6):1404.
Article PubMed PubMed Central Google Scholar
Pralow A, Hoffmann M, Nguyen-Khuong T, Pioch M, Hennig R, Genzel Y, Rapp E, Reichl U. Comprehensive N-glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells. FEBS J. 2021;288(16):4869–91.
Article CAS PubMed Google Scholar
Galan MC, Benito-Alifonso D, Watt GM. Carbohydrate chemistry in drug discovery. Org Biomol Chem. 2011;9(10):3598–610.
Article CAS PubMed Google Scholar
Karade SS, Hill ML, Kiappes JL, Manne R, Aakula B, Zitzmann N, Warfield KL, Treston AM, Mariuzza RA. N-substituted valiolamine derivatives as potent inhibitors of endoplasmic reticulum α-glucosidases I and II with antiviral activity. J Med Chem. 2021;64(24):18010–24.
Article CAS PubMed Google Scholar
Karade SS, Kolesnikov A, Treston AM, Mariuzza RA. Identification of endoplasmic reticulum α-glucosidase I from a thermophilic fungus as a platform for structure-guided antiviral drug design. Biochemistry. 2022;61(10):822–32.
Article CAS PubMed Google Scholar
Chapel C, Garcia C, Bartosch B, Roingeard P, Zitzmann N, Cosset F-L, Dubuisson J, Dwek RA, Trepo C, Zoulim F, et al. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. J Gen Virol. 2007;88(4):1133–43.
Article CAS PubMed Google Scholar
Tani H, Komoda Y, Matsuo E, Suzuki K, Hamamoto I, Yamashita T, Moriishi K, Fujiyama K, Kanto T, Hayashi N, et al. Replication-competent recombinant vesicular stomatitis virus
Comments (0)